NCT06001697

Brief Summary

The purpose of this study is to examine if and how implementing nature prescriptions can increase time in nature and improve health to yield an actionable understanding of the nature-health connection. It aims to explore how public green spaces can be better used to improve individual and community health. Finally, this study aims to advance science by conducting a randomized controlled trial to improve understanding of the linkages between time in nature and human health.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
134

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 21, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

December 18, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 23, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 23, 2025

Completed
Last Updated

May 6, 2025

Status Verified

May 1, 2025

Enrollment Period

1.3 years

First QC Date

August 14, 2023

Last Update Submit

May 2, 2025

Conditions

Keywords

NaturePark prescriptionMental healthPhysical healthChronic diseaseLifestyle

Outcome Measures

Primary Outcomes (1)

  • Nature Exposure Scale II (NES-II)

    Assess each participant's exposure to nature in everyday life. The Nature Exposure Scale II uses a 5-point likert scale for each item. Higher score means greater exposure to nature. The total score is an average of all the items included.

    Baseline and 6-months

Secondary Outcomes (12)

  • CDC Health related quality of life - 14 (CDC-HRQOL-14)

    Baseline and 6-months

  • Brief-Pittsburgh Sleep Quality Index (B-PSQI)

    Baseline and 6-months

  • Perceived Stress Scale (PSS-10)

    Baseline and 6-months

  • International Physical Activity Questionnaire Short form (IPAQ-S)

    Baseline and 6-months

  • Patient Health Questionnaire (PHQ-8/PHQ-A)

    Baseline and 6-months

  • +7 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

The treatment group will receive information regarding wellness factors by the doctor (health advice) and they will be asked to follow those recommendations for the duration of the study. In addition they will also receive a park prescription specifying a target amount of time to spend in nature, along with frequency of visits and recommended locations (e.g., specific parks), and information about parks and programming in the study area.

Behavioral: Park prescriptionBehavioral: Regular health advice

Control

OTHER

The control group will receive regular health advice and information regarding wellness factors by the doctor and they will be asked to follow those recommendations for the duration of the study.

Behavioral: Regular health advice

Interventions

The park prescription given by the patients care-provider includes information about the health benefits of spending time in nature and detailed information about the parks in the neighboring area. As well as access to a web-based platform called ParkRx which includes information and details about events in the parks in the study area. Together with information about the frequency and duration of visits to the parks.

Intervention

Regular health advice relating to lifestyle factors that can decrease the risk of chronic disease and/or reducing the burden of an existing chronic disease. Areas included are diet, physical activity, sleep, stress and medications.

ControlIntervention

Eligibility Criteria

Age13 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Participants must be a patient of the AHN Forbes Family Medicine clinic.
  • Participants must have one or more chronic conditions, or significant lifestyle risks as identified by their healthcare provider.
  • Participants must be between 13-65 years old.
  • Participants must be willing and able to provide informed consent to participate
  • Participants under 18 must be willing and able to assent for themselves and obtain parental consent.
  • Participants must be willing to comply with all study procedures for the duration of the study.
  • Participants must reside in the greater Pittsburgh area for the duration of 6-month study.
  • Participants must have a smartphone that is capable of running the Urban Mind App and connecting to the Garmin wearable device (iPhone 6 and newer as well as most Android phones).
  • Minors who participate must have their own smartphone.
  • Participants must have their own email address to register with the Urban Mind App and the Garmin App.
  • Only one participant from a household may enroll in the study.
  • Participants must be able to comprehend written English (questionnaires will be provided to participants in English).
  • Participants may not be an employee of Forbes Family Medicine clinic

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Forbes Family Medicine/AHN Research Institute

Monroeville, Pennsylvania, 15146, United States

Location

MeSH Terms

Conditions

Chronic DiseaseRisk Reduction BehaviorSedentary BehaviorDepressionAnxiety DisordersPsychological Well-Being

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehaviorBehavioral SymptomsMental DisordersPersonal Satisfaction

Study Officials

  • Gretchen Daily, PhD

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: In total a goal of 240 patients will be recruited and randomised in a 1:1 ration to either the intervention or control group. This means 120 of them will be assigned to the study group and 120 to the assigned to the control group. The intervention group will receive health advice and a park prescription by their health care provider while the control group will receive regular health advice regarding lifestyle.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 14, 2023

First Posted

August 21, 2023

Study Start

December 18, 2023

Primary Completion

April 23, 2025

Study Completion

April 23, 2025

Last Updated

May 6, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations